Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
02256
02256
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
02256 News
Abbisko Therapeutics' NDA for Pimicotinib Accepted by FDA, Promising Significant Tumor Treatment Improvements
Jan 13 2026
PRnewswire
Abbisko Therapeutics' NDA for Pimicotinib Accepted by FDA, Significant Tumor Treatment Improvement
Jan 13 2026
Yahoo Finance
<Research>CMSI Forecasts Modest Economic Growth in the US Next Year; Hong Kong Stock Market to Transition Towards Earnings-Driven Performance
Dec 11 2025
aastocks
<M Stanley Analysis: Ratings and Target Prices for Biotech Companies (Table)>
Sep 22 2025
aastocks
M Stanley: Rising Recognition Drives Biotech Stocks to Surpass Market Performance
Sep 22 2025
aastocks